These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12707067)

  • 1. Parkinsonianlike signs and risk of incident Alzheimer disease in older persons.
    Wilson RS; Schneider JA; Bienias JL; Evans DA; Bennett DA
    Arch Neurol; 2003 Apr; 60(4):539-44. PubMed ID: 12707067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline.
    Boyle PA; Wilson RS; Aggarwal NT; Tang Y; Bennett DA
    Neurology; 2006 Aug; 67(3):441-5. PubMed ID: 16894105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in body mass index and risk of incident Alzheimer disease.
    Buchman AS; Wilson RS; Bienias JL; Shah RC; Evans DA; Bennett DA
    Neurology; 2005 Sep; 65(6):892-7. PubMed ID: 16186530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.
    Arvanitakis Z; Wilson RS; Bienias JL; Evans DA; Bennett DA
    Arch Neurol; 2004 May; 61(5):661-6. PubMed ID: 15148141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in the clinical manifestations of Alzheimer disease pathology.
    Barnes LL; Wilson RS; Bienias JL; Schneider JA; Evans DA; Bennett DA
    Arch Gen Psychiatry; 2005 Jun; 62(6):685-91. PubMed ID: 15939846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loneliness and risk of Alzheimer disease.
    Wilson RS; Krueger KR; Arnold SE; Schneider JA; Kelly JF; Barnes LL; Tang Y; Bennett DA
    Arch Gen Psychiatry; 2007 Feb; 64(2):234-40. PubMed ID: 17283291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons.
    Shah RC; Wilson RS; Bienias JL; Arvanitakis Z; Evans DA; Bennett DA
    Neuroepidemiology; 2006; 26(1):30-6. PubMed ID: 16254451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grip strength and the risk of incident Alzheimer's disease.
    Buchman AS; Wilson RS; Boyle PA; Bienias JL; Bennett DA
    Neuroepidemiology; 2007; 29(1-2):66-73. PubMed ID: 17925596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly.
    Buchman AS; Boyle PA; Wilson RS; Tang Y; Bennett DA
    Psychosom Med; 2007 Jun; 69(5):483-9. PubMed ID: 17556640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of cognitive activity to risk of developing Alzheimer disease.
    Wilson RS; Scherr PA; Schneider JA; Tang Y; Bennett DA
    Neurology; 2007 Nov; 69(20):1911-20. PubMed ID: 17596582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leisure activity and cognitive decline in incident Alzheimer disease.
    Helzner EP; Scarmeas N; Cosentino S; Portet F; Stern Y
    Arch Neurol; 2007 Dec; 64(12):1749-54. PubMed ID: 18071038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of cognitive change from preclinical to clinical Alzheimer's disease.
    Jones S; Small BJ; Fratiglioni L; Backman L
    Brain Cogn; 2002 Jul; 49(2):210-3. PubMed ID: 15259392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer disease.
    Holtzer R; Wegesin DJ; Albert SM; Marder K; Bell K; Albert M; Brandt J; Stern Y
    Arch Neurol; 2003 Aug; 60(8):1137-42. PubMed ID: 12925372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of motor impairment and disability in Parkinson disease: a population-based study.
    Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
    Neurology; 2005 Nov; 65(9):1436-41. PubMed ID: 16275832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance-based physical function and future dementia in older people.
    Wang L; Larson EB; Bowen JD; van Belle G
    Arch Intern Med; 2006 May; 166(10):1115-20. PubMed ID: 16717174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive decline in high-functioning older persons is associated with an increased risk of hospitalization.
    Chodosh J; Seeman TE; Keeler E; Sewall A; Hirsch SH; Guralnik JM; Reuben DB
    J Am Geriatr Soc; 2004 Sep; 52(9):1456-62. PubMed ID: 15341546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.